The sustained release excipients market can be segmented based on type, formulation, and application. One notable sub-segment from each segment is discussed below.
Segment: Type
Sub-segment: Polymers
Polymers are a commonly used type of sustained release excipient. They offer various advantages, including controlled drug release, improved bioavailability, enhanced stability, and customized drug release rates. Polymers such as hydrogels, biodegradable polymers, and pH-sensitive polymers enable precise control and sustained release of drugs over an extended period. Furthermore, the increasing demand for biodegradable polymers in sustained release formulations promotes the growth of the polymer sub-segment within the sustained release excipients market.
Segment: Formulation
Sub-segment: Injectable
The injectable formulation sub-segment is gaining significant traction in the sustained release excipients market. Injectable sustained release formulations offer numerous advantages, such as sustained drug release, reduced dosing frequency, and improved patient compliance. They are widely utilized for the delivery of peptides, proteins, and other therapeutic agents. The growing demand for long-acting injectable formulations, especially for chronic diseases, fuels the adoption of injectable sustained release excipients, driving the growth of this sub-segment.
Segment: Application
Sub-segment: Cardiovascular Diseases
Sustained release excipients find extensive application in the treatment of cardiovascular diseases. By providing controlled drug release, sustained release excipients help in maintaining optimal drug concentrations in the bloodstream, thereby enhancing treatment efficacy and reducing the frequency of administration. These excipients are utilized in the formulation of sustained release drugs for conditions such as hypertension, angina, and heart failure. The increasing prevalence of cardiovascular diseases globally drives the demand for sustained release excipients in this application segment.
The sustained release excipients market is highly competitive, with several prominent players operating worldwide. Some of the key market players include:
1. DowDuPont Inc.
2. Ashland Global Holdings Inc.
3. Evonik Industries AG
4. BASF SE
5. Colorcon Inc.
6. Lubrizol Corporation
7. FMC Corporation
8. Roquette Freres
9. Shin-Etsu Chemical Co., Ltd.
10. Croda International Plc.
These companies focus on strategic partnerships, mergers and acquisitions, and product launches to strengthen their market position. Additionally, research and development activities aimed at developing innovative sustained release excipients are undertaken to gain a competitive edge. The sustained release excipients market is characterized by intense competition and technological advancements, driving the market players to constantly innovate and expand their product portfolios.